Dr. Michael Johnson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Oak Grove Rd, Poplar Bluff, MO 63901 Phone: 573-772-7169 Fax: 573-772-7169 |
Malarie Blackwell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2770 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-686-6974 Fax: 573-686-6975 |
Robin Robertson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-785-8218 |
Dr. Carol Morris Clark, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-778-4241 Fax: 573-778-4246 |
Ms. Linda Carol Bryeans-burfield, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-778-4108 Fax: 573-778-4246 |
Timothy Aaron King, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-778-4672 |
Dr. Kayla Dowell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Oak Grove Rd, Poplar Bluff, MO 63901 Phone: 573-772-7164 |
Catherine Elizabeth Wilcoxon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-778-4247 |
Dr. Whitney Laura Chronister, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 W Pine St, Poplar Bluff, MO 63901 Phone: 573-718-9704 |
Dr. Stephanie Morgan Berrong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-686-4151 Fax: 573-778-4246 |
Mr. Kenneth Gregory Popp Ii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 225 Physicians Park Ste 100, Poplar Bluff, MO 63901 Phone: 573-778-9238 |
Aaron Vincent Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 W Pine St, Poplar Bluff, MO 63901 Phone: 573-785-0984 |
Mr. Robert Joseph Tonner Jr., RPH PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1301 Shelby Road, Poplar Bluff, MO 63901 Phone: 573-778-9156 Fax: 573-778-9263 |
Paige Raelyn Reinbott, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-785-8218 |
Mr. Dennis D Henson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 686 Lester St, Poplar Bluff, MO 63901 Phone: 573-686-2411 |
Mrs. Jennifer Rebecca Hawkins, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-778-4147 |
Dennis Leroy Kurz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2770 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-686-6974 Fax: 573-686-6975 |
Sharon Joseph Aykara Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 Oak Grove Rd, Poplar Bluff, MO 63901 Phone: 573-772-7169 |
Mr. Martin H Michel, R.PH., M.B.A., C.D.E Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-785-8218 Fax: 573-785-8125 |
Taylor Capps Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 N Westwood Blvd, Poplar Bluff, MO 63901 Phone: 573-785-8218 |
News Archive
As part of its research commitment on bisphenol A (BPA), Health Canada released today the results of a new survey of BPA exposure levels in a variety of soft drink and beer products. The results from this latest government survey provide confirmation that foods and beverages packaged in BPA epoxy resin coated metal cans do not pose a health risk.
After more than two years of investigation, CVS Caremark agreed on Thursday to pay $5 million to settle charges by the Federal Trade Commission that the company had misrepresented the price of certain prescription drugs in one of its Medicare drug plans, causing many older consumers to pay significantly higher prices than advertised.
Cancer can be treated by a number of different ways depending on the location, grade and stage of tumour. A patient's age, medical history and lifestyle will also be taken into consideration and a combination of treatments will also be adopted to provide maximum effect.
Anadys Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with certain institutional investors to raise approximately $12.5 million in gross proceeds in a "registered direct" offering through the sale of a total of 5,813,954 shares of its common stock at an offering price of $2.15 per share. Anadys estimates that net proceeds from the offering will be approximately $11.3 million, after deducting placement agents' fees and estimated offering expenses.
› Verified 9 days ago